Weight loss drugs without side effects? Top researchers propose new approach
statnews.com • • business
Key Points:
- Researchers led by Richard DiMarchi and Matthias Tschöp have developed an experimental drug targeting GIP and glucagon receptors, suggesting it may induce weight loss without involving the GLP-1 hormone.
- Their studies in rodents and monkeys indicate this drug could achieve weight loss comparable to GLP-1-based treatments but with fewer side effects like nausea and vomiting.
- The findings, published in Molecular Metabolism and funded by BlueWater Biosciences, challenge the prevailing belief that GLP-1 targeting is essential for effective obesity drugs.
- Human clinical trials are needed to confirm these results, as animal study outcomes often do not translate directly to humans.
- This new hypothesis could provoke debate within the scientific community and influence future obesity drug development strategies.
